Hideaki Miyake Selected Research

Creatinine

1/2017	Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients.
8/2015	Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib.
1/2015	Surgery-related outcomes and postoperative split renal function by scintigraphy evaluation in robot-assisted partial nephrectomy in complex renal tumors: an initial case series.
2/2004	Significance of renal function in changes in acid-base metabolism after orthotopic bladder replacement: colon neobladder compared with ileal neobladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Miyake Research Topics

Disease

129	Neoplasms (Cancer) 05/2024 - 01/2002
127	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 05/2002
99	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 02/2002
37	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2002
31	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2002
21	Lymphatic Metastasis 01/2022 - 10/2004
19	Disease Progression 05/2024 - 01/2002
17	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017 - 03/2002
15	Carcinoma (Carcinomatosis) 05/2024 - 12/2011
12	Margins of Excision 01/2016 - 01/2006
10	Non-Muscle Invasive Bladder Neoplasms 05/2024 - 01/2011
10	Hypertension (High Blood Pressure) 02/2024 - 01/2011
7	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2022 - 11/2002
7	Transitional Cell Carcinoma 11/2006 - 01/2002
6	Neoplasm Micrometastasis 07/2013 - 05/2005
5	Thrombosis (Thrombus) 03/2024 - 09/2007
5	Carcinoma in Situ 05/2022 - 12/2002
5	Inflammation (Inflammations) 01/2022 - 01/2007
5	Thrombocytopenia (Thrombopenia) 07/2016 - 02/2013
5	Infections 01/2014 - 08/2011
4	Urologic Neoplasms (Urological Cancer) 04/2024 - 06/2007
4	Proteinuria 02/2024 - 08/2015
4	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2005
4	Fatigue 05/2020 - 06/2014
4	Ischemia 02/2020 - 04/2009
4	Hand-Foot Syndrome 02/2019 - 06/2014
4	Anemia 07/2016 - 11/2012
4	Testicular Neoplasms (Testicular Cancer) 04/2013 - 03/2002
4	Nonseminomatous germ cell tumor 10/2010 - 09/2004
3	Residual Neoplasm 05/2024 - 07/2015
3	Adenocarcinoma 03/2019 - 06/2002

Drug/Important Bio-Agent (IBA)

32	Prostate-Specific Antigen (Semenogelase)IBA 01/2024 - 06/2002
30	AndrogensIBA 05/2024 - 05/2002
22	C-Reactive ProteinIBA 04/2021 - 05/2009
21	ClusterinIBA 01/2017 - 01/2002
20	Sunitinib (Sutent)FDA Link 02/2024 - 10/2010
19	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 09/2003
19	Tyrosine Kinase InhibitorsIBA 02/2024 - 10/2010
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
17	Docetaxel (Taxotere)FDA Link 01/2024 - 03/2005
13	NivolumabIBA 05/2024 - 01/2019
11	Androgen Receptors (Androgen Receptor)IBA 05/2024 - 11/2010
11	Axitinib (AG 013736)IBA 04/2024 - 08/2015
11	Hormones (Hormone)IBA 01/2024 - 07/2003
11	TOR Serine-Threonine KinasesIBA 01/2017 - 11/2012
10	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2019
9	Therapeutic UsesIBA 04/2024 - 09/2005
9	OligodeoxyribonucleotidesIBA 12/2014 - 06/2004
9	Messenger RNA (mRNA)IBA 11/2012 - 01/2002
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 09/2005
8	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 09/2010
7	cabazitaxel FDA Link 01/2022 - 08/2017
7	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 02/2005
7	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 10/2006
7	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017 - 10/2006
7	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2013 - 03/2002
7	Antisense OligonucleotidesIBA 06/2011 - 05/2002
6	pembrolizumabIBA 12/2023 - 04/2021
5	PlatinumIBA 05/2024 - 03/2011
5	AcidsIBA 05/2024 - 02/2004
5	CytokinesIBA 01/2023 - 12/2011
5	enzalutamideIBA 01/2022 - 01/2017
5	Gemcitabine FDA Link 05/2021 - 06/2004
5	Ifosfamide FDA LinkGeneric 01/2017 - 10/2006
5	Small Interfering RNA (siRNA)IBA 11/2013 - 07/2010
4	IpilimumabIBA 04/2024 - 01/2020
4	bicalutamide (Casodex)FDA LinkGeneric 03/2022 - 10/2005
4	Abiraterone AcetateIBA 03/2022 - 01/2017
4	AlbuminsIBA 04/2021 - 01/2017
4	Androgen Antagonists (Antiandrogens)IBA 07/2019 - 01/2008
4	temsirolimus FDA Link 01/2017 - 11/2012
4	CreatinineIBA 01/2017 - 02/2004
4	AntigensIBA 07/2013 - 01/2004
4	Interleukin-2 (IL2)IBA 12/2011 - 10/2005
3	avelumabIBA 05/2024 - 03/2020
3	cabozantinibIBA 04/2024 - 11/2023
3	LigandsIBA 04/2024 - 01/2017
3	AntibodiesIBA 06/2023 - 11/2016
3	Radium-223IBA 05/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2007

Therapy/Procedure

118	Therapeutics 05/2024 - 05/2002
68	Prostatectomy (Retropubic Prostatectomy) 04/2024 - 11/2002
44	Nephrectomy 04/2024 - 02/2002
37	Castration 05/2024 - 06/2002
37	Drug Therapy (Chemotherapy) 05/2024 - 03/2003
16	Cystectomy 05/2022 - 01/2002
9	Nephroureterectomy 04/2024 - 01/2008
9	Radiotherapy 01/2022 - 06/2002
8	Lymph Node Excision (Lymph Node Dissection) 08/2022 - 03/2004
8	Molecular Targeted Therapy 01/2021 - 10/2010
8	Neoadjuvant Therapy 11/2013 - 07/2003
7	Aftercare (After-Treatment) 04/2024 - 04/2011
7	Combination Drug Therapy (Combination Chemotherapy) 01/2023 - 09/2003
7	Operative Time 05/2022 - 11/2013
6	Transurethral Resection of Bladder 05/2024 - 01/2003
6	Warm Ischemia 01/2022 - 01/2015
6	Immunotherapy 04/2013 - 01/2004
4	Thrombectomy 03/2024 - 09/2007
4	Intravesical Administration 08/2011 - 01/2003
4	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2007 - 07/2004